Person · CIK 1724311

Alexander O. Schuth

COFO and Secretary at Denali Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$18.5M

Noticed on Form 144$3.1M

Bought on Form 4$0

Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Denali Therapeutics DNLI	Common Stock	Directly	278,995	Sep 1, 2026 · Filing · EDGAR
Denali Therapeutics DNLI	Common Stock	See footnote	523,749	Sep 1, 2026 · Filing · EDGAR
Denali Therapeutics DNLI	Stock Option (right to buy) exercise $16.27, expires Jan 3, 2036, into Common Stock	Directly	173,100	Jan 3, 2026 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q3 2026	$137K	$66K
Q1 2026	$284K	$284K
Q3 2025	$40K	$40K
Q1 2025	$308K	$308K
Q4 2024	$465K	$460K
Q3 2024	$252K	$251K
Q1 2024	$596K	$584K
Q3 2023	$836K	$540K
Q2 2023	$536K	$572K
Q1 2023	$606K	Not machine-readable
Q3 2022	$86K	Not machine-readable
Q1 2022	$277K	Not machine-readable
Q4 2021	$1.5M	Not machine-readable
Q3 2021	$2M	Not machine-readable
Q2 2021	$1.8M	Not machine-readable
Q1 2021	$6.9M	Not machine-readable
Q1 2020	$28K	Not machine-readable
Q4 2019	$405K	Not machine-readable
Q3 2019	$429K	Not machine-readable
Q2 2019	$517K	Not machine-readable
Q1 2019	$465K	Not machine-readable
Q4 2018	$153K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Denali Therapeutics DNLI · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 27, 2026 · 1 notice
Sep 1, 2026	2,768 · ~$66K	Sep 1, 2026	Sold as noticed Sold 2,768 at $23.44 on Sep 1 · $65K Form 4	Filing · EDGAR
Denali Therapeutics DNLI · Morgan Stanley Smith Barney · No 10b5-1 plan stated · 8 notices
Jan 6, 2026	17,218 · ~$284K	Jan 6, 2026	Sold as noticed Sold 17,218 at $16.50 on Jan 6 · $284K Form 4	Filing · EDGAR
Aug 12, 2025	2,937 · ~$40K	Aug 12, 2025	Sold as noticed Sold 2,937 at $13.58 on Aug 12 · $40K Form 4	Filing · EDGAR
Jan 7, 2025	2,907 · ~$60K	Jan 7, 2025	Sold as noticed Sold 2,907 at $20.81 on Jan 7 · $60K Form 4	Filing · EDGAR
Jan 7, 2025	12,255 · ~$248K	Jan 6, 2025	Sold as noticed Sold 12,255 at $20.22 on Jan 6 · $248K Form 4	Filing · EDGAR
Aug 20, 2024	2,453 · ~$58K	Aug 20, 2024	Sold as noticed Sold 2,453 at $23.79 on Aug 20 · $58K Form 4	Filing · EDGAR
Aug 13, 2024	2,272 · ~$52K	Aug 13, 2024	Sold as noticed Sold 2,272 at $22.89 on Aug 13 · $52K Form 4	Filing · EDGAR
Feb 13, 2024	2,716 · ~$47K	Feb 13, 2024	Sold as noticed Sold 2,716 at $17.29 on Feb 13 · $47K Form 4	Filing · EDGAR
Jan 5, 2024	9,972 · ~$194K	Jan 5, 2024	Sold as noticed Sold 9,972 at $19.43 on Jan 5 · $194K Form 4	Filing · EDGAR
Denali Therapeutics DNLI · Morgan Stanley Smith Barney · 10b5-1 plan adopted Sep 29, 2023 · 4 notices
Nov 7, 2024	15,558 · ~$460K	Nov 7, 2024	Sold as noticed Sold 15,558 in 3 sales, Nov 7 to Nov 7 · $465K Form 4	Filing · EDGAR
Aug 21, 2024	2,547 · ~$60K	Aug 21, 2024	Sold as noticed Sold 2,547 at $24.78 on Aug 21 · $63K Form 4	Filing · EDGAR
Aug 20, 2024	3,353 · ~$80K	Aug 20, 2024	Sold as noticed Sold 3,353 at $23.54 on Aug 20 · $79K Form 4	Filing · EDGAR
Feb 14, 2024	20,128 · ~$343K	Feb 14, 2024	Sold as noticed Sold 20,128 at $17.66 on Feb 14 · $355K Form 4	Filing · EDGAR
Denali Therapeutics DNLI · Charles Schwab · 10b5-1 plan adopted Sep 30, 2022 · 4 notices
Aug 23, 2023	2,522 · ~$58K	Aug 23, 2023	Sold as noticed Sold 2,522 at $23.17 on Aug 23 · $58K Form 4	Filing · EDGAR
Aug 14, 2023	2,772 · ~$66K	Aug 14, 2023	Sold as noticed Sold 2,772 at $23.67 on Aug 14 · $66K Form 4	Filing · EDGAR
Jul 18, 2023	9,702 · ~$291K	Jul 18, 2023	Sold as noticed Sold 9,702 at $30.01 on Jul 18 · $291K Form 4	Filing · EDGAR
May 15, 2023	20,000 · ~$572K	May 15, 2023	Sold as noticed Sold 20,000 in 3 sales, May 15 to Jul 17 · $582K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Denali Therapeutics DNLI · Charles Schwab · No 10b5-1 plan stated · 2 notices
Aug 21, 2023	2,478 · ~$56K	Aug 21, 2023	Sold as noticed Sold 2,478 at $22.59 on Aug 21 · $56K Form 4	Filing · EDGAR
Aug 10, 2023	2,853 · ~$69K	Aug 10, 2023	Sold as noticed Sold 2,853 at $24.18 on Aug 10 · $69K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 98 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Denali Therapeutics (DNLI): Sold 2,857 at $25.07 on Aug 11, 2026 · $72K	Filing · EDGAR
—	—	—	Sold without notice Denali Therapeutics (DNLI): Sold 4,898 at $25.04 on Apr 13, 2023 · $123K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 5,102 at $25.04 on Apr 12, 2023 · $128K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 3,497 at $30.09 on Feb 13, 2023 · $105K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,521 at $30.89 on Feb 8, 2023 · $47K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 114 at $29.87 on Jan 17, 2023 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 9,886 at $29.53 on Jan 17, 2023 · $292K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,636 at $28.44 on Jan 5, 2023 · $75K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,912 at $28.70 on Jan 4, 2023 · $84K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,576 at $33.22 on Aug 19, 2022 · $86K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,803 at $34.68 on Feb 11, 2022 · $97K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,423 at $37.10 on Feb 9, 2022 · $53K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,846 at $44.77 on Jan 5, 2022 · $127K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 7,200 at $42.45 on Dec 6, 2021 · $306K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,800 at $41.82 on Dec 6, 2021 · $117K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 3,283 at $53.23 on Nov 4, 2021 · $175K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 6,717 at $52.65 on Nov 4, 2021 · $354K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 4,006 at $51.04 on Oct 4, 2021 · $204K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 5,994 at $50.24 on Oct 4, 2021 · $301K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,441 at $56.05 on Sep 7, 2021 · $137K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 5,350 at $55.67 on Sep 7, 2021 · $298K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,209 at $54.70 on Sep 7, 2021 · $121K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 196 at $50.10 on Aug 19, 2021 · $10K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,348 at $49.56 on Aug 19, 2021 · $116K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 200 at $52.99 on Aug 4, 2021 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 8,236 at $52.34 on Aug 4, 2021 · $431K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,564 at $51.52 on Aug 4, 2021 · $81K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 10,000 at $76.20 on Jul 6, 2021 · $762K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 4,340 at $64.82 on Jun 4, 2021 · $281K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 5,660 at $64.35 on Jun 4, 2021 · $364K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 445 at $57.39 on May 4, 2021 · $26K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 3,557 at $55.92 on May 4, 2021 · $199K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 5,998 at $55.09 on May 4, 2021 · $330K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 700 at $57.44 on Apr 5, 2021 · $40K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 4,156 at $56.47 on Apr 5, 2021 · $235K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 5,144 at $55.60 on Apr 5, 2021 · $286K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,878 at $61.58 on Mar 4, 2021 · $116K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 8,122 at $60.89 on Mar 4, 2021 · $495K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 433 at $71.41 on Feb 11, 2021 · $31K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,614 at $70.17 on Feb 11, 2021 · $183K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 206 at $75.68 on Feb 9, 2021 · $16K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,262 at $74.66 on Feb 9, 2021 · $94K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,912 at $68.61 on Feb 4, 2021 · $131K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 6,509 at $67.90 on Feb 4, 2021 · $442K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,579 at $66.65 on Feb 4, 2021 · $105K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,226 at $84.17 on Jan 4, 2021 · $103K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,900 at $82.96 on Jan 4, 2021 · $158K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 7,996 at $82.14 on Jan 4, 2021 · $657K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,817 at $81.45 on Jan 4, 2021 · $229K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 3,598 at $79.78 on Jan 4, 2021 · $287K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 7,876 at $78.43 on Jan 4, 2021 · $618K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,472 at $77.64 on Jan 4, 2021 · $114K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 980 at $76.41 on Jan 4, 2021 · $75K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 700 at $75.61 on Jan 4, 2021 · $53K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 5,144 at $74.01 on Jan 4, 2021 · $381K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 4,626 at $73.09 on Jan 4, 2021 · $338K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 8,531 at $72.22 on Jan 4, 2021 · $616K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 9,709 at $71.03 on Jan 4, 2021 · $690K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 9,340 at $70.10 on Jan 4, 2021 · $655K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,067 at $69.07 on Jan 4, 2021 · $74K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 518 at $67.78 on Jan 4, 2021 · $35K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,100 at $66.58 on Jan 4, 2021 · $73K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,400 at $65.17 on Jan 4, 2021 · $91K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,427 at $19.49 on Mar 30, 2020 · $28K	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 3,121 at $18.00 on Dec 4, 2019 · $56K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,656 at $18.00 on Dec 4, 2019 · $48K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 711 at $18.01 on Dec 3, 2019 · $13K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,012 at $18.01 on Dec 3, 2019 · $18K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 229 at $18.02 on Nov 26, 2019 · $4K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 14,125 at $18.02 on Nov 25, 2019 · $255K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 646 at $18.00 on Nov 22, 2019 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 7,500 at $18.16 on Sep 9, 2019 · $136K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 7,500 at $18.81 on Aug 7, 2019 · $141K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 400 at $20.90 on Jul 8, 2019 · $8K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 7,100 at $20.25 on Jul 8, 2019 · $144K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 7,500 at $18.77 on Jun 10, 2019 · $141K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $21.09 on May 13, 2019 · $53K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $22.19 on May 10, 2019 · $55K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $22.86 on May 9, 2019 · $57K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,512 at $27.73 on Apr 11, 2019 · $70K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,513 at $28.26 on Apr 10, 2019 · $71K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,475 at $28.17 on Apr 9, 2019 · $70K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,512 at $24.33 on Mar 13, 2019 · $37K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,000 at $23.60 on Mar 13, 2019 · $24K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,513 at $22.40 on Mar 12, 2019 · $56K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 275 at $21.80 on Mar 11, 2019 · $6K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,200 at $21.20 on Mar 11, 2019 · $47K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,700 at $20.24 on Feb 12, 2019 · $34K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 800 at $19.73 on Feb 12, 2019 · $16K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,266 at $19.35 on Feb 11, 2019 · $24K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 1,234 at $18.74 on Feb 11, 2019 · $23K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $18.11 on Feb 8, 2019 · $45K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $20.80 on Jan 11, 2019 · $52K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $19.99 on Jan 10, 2019 · $50K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $20.31 on Jan 9, 2019 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $20.80 on Dec 12, 2018 · $52K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $20.22 on Dec 11, 2018 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Denali Therapeutics (DNLI): Sold 2,500 at $20.18 on Dec 10, 2018 · $50K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Denali Therapeutics DNLI Cofo and Secretary · filings 2017 to 2026 · sold $18.5M · $3.1M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 1, 2026	Sale under a 10b5-1 plan	−2,768	$23.44	$65K	278,995 direct	Filing · EDGAR
Aug 11, 2026	Open-market or private sale	−2,857	$25.07	$72K	281,763 direct	Filing · EDGAR
Jan 6, 2026	Open-market or private sale	−17,218	$16.50	$284K	282,828 direct	Filing · EDGAR
Jan 3, 2026	Grant or award from the company	+57,700			300,046 direct	Filing · EDGAR
Jan 3, 2026	Grant or award from the company Stock Option (right to buy)	+173,100			173,100 direct	Filing · EDGAR
Aug 12, 2025	Open-market or private sale	−2,937	$13.58	$40K	242,346 direct	Filing · EDGAR
Jan 7, 2025	Open-market or private sale	−2,907	$20.81	$60K	244,308 direct	Filing · EDGAR
Jan 6, 2025	Open-market or private sale	−12,255	$20.22	$248K	247,215 direct	Filing · EDGAR
Jan 3, 2025	Grant or award from the company	+54,180			259,470 direct	Filing · EDGAR
Jan 3, 2025	Grant or award from the company Stock Option (right to buy)	+162,540			162,540 direct	Filing · EDGAR
Dec 27, 2024	Option or RSU exercised or converted	+6,708	$5.28	$35K	205,290 direct	Filing · EDGAR
Dec 27, 2024	Option or RSU exercised or converted Stock Option (right to buy)	−6,708			46,671 direct	Filing · EDGAR
Nov 22, 2024	Option or RSU exercised or converted	+20,516	$0.68	$14K	198,582 direct	Filing · EDGAR
Nov 22, 2024	Option or RSU exercised or converted Stock Option (right to buy)	−20,516			124,562 direct	Filing · EDGAR
Nov 7, 2024	Option or RSU exercised or converted	+15,558	$5.28	$82K	193,624 direct	Filing · EDGAR
Nov 7, 2024	Sale under a 10b5-1 plan	−12,333	$29.68	$366K	181,291 direct	Filing · EDGAR
Nov 7, 2024	Sale under a 10b5-1 plan	−2,925	$30.72	$90K	178,366 direct	Filing · EDGAR
Nov 7, 2024	Sale under a 10b5-1 plan	−300	$31.29	$9K	178,066 direct	Filing · EDGAR
Nov 7, 2024	Option or RSU exercised or converted Stock Option (right to buy)	−15,558			53,379 direct	Filing · EDGAR
Aug 21, 2024	Sale under a 10b5-1 plan	−2,547	$24.78	$63K	178,066 direct	Filing · EDGAR
Aug 20, 2024	Sale under a 10b5-1 plan	−2,453	$23.79	$58K	183,966 direct	Filing · EDGAR
Aug 20, 2024	Sale under a 10b5-1 plan	−3,353	$23.54	$79K	180,613 direct	Filing · EDGAR
Aug 13, 2024	Open-market or private sale	−2,272	$22.89	$52K	186,419 direct	Filing · EDGAR
Feb 14, 2024	Sale under a 10b5-1 plan	−20,128	$17.66	$355K	187,341 direct	Filing · EDGAR
Feb 13, 2024	Sale under a 10b5-1 plan	−2,716	$17.29	$47K	207,469 direct	Filing · EDGAR
Feb 8, 2024	Option or RSU exercised or converted	+50,000	$0.68	$34K	210,185 direct	Filing · EDGAR
Feb 8, 2024	Option or RSU exercised or converted Stock Option (right to buy)	−50,000			145,078 direct	Filing · EDGAR
Jan 5, 2024	Open-market or private sale	−9,972	$19.43	$194K	539,307 See footnote	Filing · EDGAR
Jan 3, 2024	Grant or award from the company	+53,720			170,157 direct	Filing · EDGAR
Jan 3, 2024	Grant or award from the company Stock Option (right to buy)	+161,160			161,160 direct	Filing · EDGAR
Aug 23, 2023	Sale under a 10b5-1 plan	−2,522	$23.17	$58K	518,989 See footnote	Filing · EDGAR
Aug 21, 2023	Open-market or private sale	−2,478	$22.59	$56K	521,511 See footnote	Filing · EDGAR
Aug 14, 2023	Sale under a 10b5-1 plan	−2,772	$23.67	$66K	518,989 See footnote	Filing · EDGAR
Aug 10, 2023	Open-market or private sale	−2,853	$24.18	$69K	521,761 See footnote	Filing · EDGAR
Jul 18, 2023	Sale under a 10b5-1 plan	−9,702	$30.01	$291K	518,989 See footnote	Filing · EDGAR
Jul 17, 2023	Option or RSU exercised or converted	+10,000	$5.28	$53K	538,691 See footnote	Filing · EDGAR
Jul 17, 2023	Sale under a 10b5-1 plan	−10,000	$29.60	$296K	528,691 See footnote	Filing · EDGAR
Jul 17, 2023	Option or RSU exercised or converted Stock Option (right to buy)	−10,000			68,937 direct	Filing · EDGAR
May 15, 2023	Option or RSU exercised or converted	+10,000	$5.28	$53K	538,691 See footnote	Filing · EDGAR
May 15, 2023	Sale under a 10b5-1 plan	−9,200	$28.55	$263K	529,491 See footnote	Filing · EDGAR
May 15, 2023	Sale under a 10b5-1 plan	−800	$29.23	$23K	528,691 See footnote	Filing · EDGAR
May 15, 2023	Option or RSU exercised or converted Stock Option (right to buy)	−10,000			78,937 direct	Filing · EDGAR
Apr 13, 2023	Option or RSU exercised or converted	+4,898	$5.28	$26K	533,589 See footnote	Filing · EDGAR
Apr 13, 2023	Sale under a 10b5-1 plan	−4,898	$25.04	$123K	528,691 See footnote	Filing · EDGAR
Apr 13, 2023	Option or RSU exercised or converted Stock Option (right to buy)	−4,898			88,937 direct	Filing · EDGAR
Apr 12, 2023	Option or RSU exercised or converted	+5,102	$5.28	$27K	533,793 See footnote	Filing · EDGAR
Apr 12, 2023	Sale under a 10b5-1 plan	−5,102	$25.04	$128K	528,691 See footnote	Filing · EDGAR
Apr 12, 2023	Option or RSU exercised or converted Stock Option (right to buy)	−5,102			93,835 direct	Filing · EDGAR
Feb 13, 2023	Option or RSU exercised or converted	+25,000	$0.68	$17K	524,902 See footnote	Filing · EDGAR
Feb 13, 2023	Open-market or private sale	−3,497	$30.09	$105K	528,691 See footnote	Filing · EDGAR
Feb 13, 2023	Option or RSU exercised or converted Stock Option (right to buy)	−25,000			195,078 direct	Filing · EDGAR
Feb 8, 2023	Open-market or private sale	−1,521	$30.89	$47K	499,902 See footnote	Filing · EDGAR
Jan 17, 2023	Option or RSU exercised or converted	+10,000	$5.28	$53K	507,173 See footnote	Filing · EDGAR
Jan 17, 2023	Sale under a 10b5-1 plan	−9,886	$29.53	$292K	497,287 See footnote	Filing · EDGAR
Jan 17, 2023	Sale under a 10b5-1 plan	−114	$29.87	$3K	497,173 See footnote	Filing · EDGAR
Jan 17, 2023	Option or RSU exercised or converted Stock Option (right to buy)	−10,000			98,937 direct	Filing · EDGAR
Jan 5, 2023	Open-market or private sale	−2,636	$28.44	$75K	497,173 See footnote	Filing · EDGAR
Jan 4, 2023	Open-market or private sale	−2,912	$28.70	$84K	492,309 See footnote	Filing · EDGAR
Jan 3, 2023	Grant or award from the company	+41,120			157,578 direct	Filing · EDGAR
Jan 3, 2023	Grant or award from the company Stock Option (right to buy)	+123,360			123,360 direct	Filing · EDGAR

127 earlier transactions are in the filing list below.

All 98 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 3, 2026	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Sep 1, 2026	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 13, 2026	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 11, 2026	Form 144	Could not read	EDGAR
Jan 8, 2026	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 6, 2026	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Jan 5, 2026	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 14, 2025	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 12, 2025	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Jan 8, 2025	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 7, 2025	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Jan 7, 2025	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Jan 7, 2025	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Dec 31, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Nov 26, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Nov 12, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Nov 7, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 22, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 21, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 20, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 20, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 15, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 13, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Feb 15, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 14, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Feb 13, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Feb 12, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 9, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 5, 2024	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Jan 5, 2024	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 25, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 23, 2023	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 23, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 21, 2023	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 16, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 14, 2023	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Aug 14, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 10, 2023	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Jul 19, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jul 18, 2023	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
May 17, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
May 15, 2023	Form 144	Denali Therapeutics DNLI	Filing · EDGAR
Apr 14, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 15, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 10, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 19, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 9, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 9, 2023	Form 4/A	Denali Therapeutics DNLI	Filing · EDGAR
Jan 5, 2023	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Oct 12, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 23, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 11, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 15, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 11, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 7, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 5, 2022	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Dec 8, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Nov 8, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Oct 6, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Sep 22, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Sep 9, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 23, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 6, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jul 8, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jun 8, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
May 6, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Apr 6, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Mar 4, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 16, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 11, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 5, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 6, 2021	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Nov 30, 2020	Form 4/A	Denali Therapeutics DNLI	Filing · EDGAR
Aug 24, 2020	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 20, 2020	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Apr 1, 2020	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Apr 1, 2020	Form 4/A	Denali Therapeutics DNLI	Filing · EDGAR
Feb 12, 2020	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Dec 5, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Nov 26, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Oct 25, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Sep 11, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 22, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 9, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jul 10, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jun 12, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
May 13, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Apr 11, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Mar 13, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 12, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 11, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jan 11, 2019	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Dec 12, 2018	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Oct 3, 2018	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Aug 22, 2018	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Jun 26, 2018	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Feb 28, 2018	Form 4	Denali Therapeutics DNLI	Filing · EDGAR
Dec 7, 2017	Form 3	Denali Therapeutics DNLI	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 9:27 PM ET. The filing on SEC.gov is the record.